Haiping G. Dai-Drexler

Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 56 publications

Quantification of isavuconazole in dried blood spots by LC-MS/MS and clinical application for therapeutic drug monitoring.

Quantification of isavuconazole in dried blood spots by LC-MS/MS and clinical application for therapeutic drug monitoring.

Journal: Journal of pharmaceutical and biomedical analysis

Published: February 05, 2026

Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements.

Therapeutic Advances in Adult B-cell Acute Lymphoblastic Leukemia with KMT2A Rearrangements.

Journal: Annals of hematology

Published: January 07, 2026

BiRD Regimen Followed by Anti-BCMA CAR-T Cell Immunotherapy as First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 2 Trial.

BiRD Regimen Followed by Anti-BCMA CAR-T Cell Immunotherapy as First-Line Therapy for Newly Diagnosed Multiple Myeloma: A Prospective, Single-Arm, Phase 2 Trial.

Journal: American journal of hematology

Published: December 27, 2025

Regulated expression of miR-99a and miR-100 relates clinical and prognostic parameters of acute myeloid leukemia.

Regulated expression of miR-99a and miR-100 relates clinical and prognostic parameters of acute myeloid leukemia.

Journal: Hematology (Amsterdam, Netherlands)

Published: December 02, 2025

IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms.

IKZF1N159S is associated with adverse outcomes in patients with myelodysplastic neoplasms.

Journal: Leukemia

Published: October 22, 2025

Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study.

Integrative clinical and molecular characterization of an acute promyelocytic leukemia-like subgroup with high early death risk in newly diagnosed acute myeloid leukemia: a multicenter study.

Journal: Haematologica

Published: July 07, 2025

Developing a Framework of Entrustable Professional Activities for Residency Training in Hematology.

Developing a Framework of Entrustable Professional Activities for Residency Training in Hematology.

Journal: Advances in medical education and practice

Published: June 04, 2025

Adult AML with NUP98 rearrangements should be stratified into adverse-risk group.

Adult AML with NUP98 rearrangements should be stratified into adverse-risk group.

Journal: Blood cancer journal

Published: April 09, 2025

Relationship between sleep quality and the risk of all-cause mortality in elderly people aged 60 and above in Shanghai: a prospective cohort study

Relationship between sleep quality and the risk of all-cause mortality in elderly people aged 60 and above in Shanghai: a prospective cohort study

Journal: Zhonghua yi xue za zhi

Published: April 03, 2025

Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation.

Treatment outcome and efficacy of desensitization strategies for immunized-PTR in hematological malignancies before hematopoietic stem cell transplantation.

Journal: Bone marrow transplantation

Published: March 19, 2025

Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.

Quantification of the FLT3 internal tandem duplication is a reliable marker for monitoring measurable residual disease in acute myeloid leukemia with FLT3-ITD mutations.

Journal: Bone marrow transplantation

Published: November 10, 2024

Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD.

Reduced-dose chemotherapy followed by blinatumomab for newly diagnosed philadelphia chromosome-negative B-cell precursor acute lymphoblastic leukemia: a propensity-matched comparison with hyper-CVAD.

Journal: Discover oncology

Published: November 06, 2024

Showing 1-12 of 56

Last Updated: 09/26/2026